These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 18596201)
21. Conformational instability of the MARK3 UBA domain compromises ubiquitin recognition and promotes interaction with the adjacent kinase domain. Murphy JM; Korzhnev DM; Ceccarelli DF; Briant DJ; Zarrine-Afsar A; Sicheri F; Kay LE; Pawson T Proc Natl Acad Sci U S A; 2007 Sep; 104(36):14336-41. PubMed ID: 17726107 [TBL] [Abstract][Full Text] [Related]
22. Dimerisation of the UBA domain of p62 inhibits ubiquitin binding and regulates NF-kappaB signalling. Long J; Garner TP; Pandya MJ; Craven CJ; Chen P; Shaw B; Williamson MP; Layfield R; Searle MS J Mol Biol; 2010 Feb; 396(1):178-94. PubMed ID: 19931284 [TBL] [Abstract][Full Text] [Related]
23. Suppressors of T-cell receptor signaling Sts-1 and Sts-2 bind to Cbl and inhibit endocytosis of receptor tyrosine kinases. Kowanetz K; Crosetto N; Haglund K; Schmidt MHH; Heldin CH; Dikic I J Biol Chem; 2004 Jul; 279(31):32786-95. PubMed ID: 15159412 [TBL] [Abstract][Full Text] [Related]
24. The N terminus of Cbl-c regulates ubiquitin ligase activity by modulating affinity for the ubiquitin-conjugating enzyme. Ryan PE; Sivadasan-Nair N; Nau MM; Nicholas S; Lipkowitz S J Biol Chem; 2010 Jul; 285(31):23687-98. PubMed ID: 20525694 [TBL] [Abstract][Full Text] [Related]
25. Regulation of ubiquitin protein ligase activity in c-Cbl by phosphorylation-induced conformational change and constitutive activation by tyrosine to glutamate point mutations. Kassenbrock CK; Anderson SM J Biol Chem; 2004 Jul; 279(27):28017-27. PubMed ID: 15117950 [TBL] [Abstract][Full Text] [Related]
26. Autoinhibition and phosphorylation-induced activation mechanisms of human cancer and autoimmune disease-related E3 protein Cbl-b. Kobashigawa Y; Tomitaka A; Kumeta H; Noda NN; Yamaguchi M; Inagaki F Proc Natl Acad Sci U S A; 2011 Dec; 108(51):20579-84. PubMed ID: 22158902 [TBL] [Abstract][Full Text] [Related]
27. Solution structure of the ubiquitin-associated (UBA) domain of human autophagy receptor NBR1 and its interaction with ubiquitin and polyubiquitin. Walinda E; Morimoto D; Sugase K; Konuma T; Tochio H; Shirakawa M J Biol Chem; 2014 May; 289(20):13890-902. PubMed ID: 24692539 [TBL] [Abstract][Full Text] [Related]
28. Solution structure of the flexible class II ubiquitin-conjugating enzyme Ubc1 provides insights for polyubiquitin chain assembly. Merkley N; Shaw GS J Biol Chem; 2004 Nov; 279(45):47139-47. PubMed ID: 15328341 [TBL] [Abstract][Full Text] [Related]
29. Ubiquitin recognition by the ubiquitin-associated domain of p62 involves a novel conformational switch. Long J; Gallagher TR; Cavey JR; Sheppard PW; Ralston SH; Layfield R; Searle MS J Biol Chem; 2008 Feb; 283(9):5427-40. PubMed ID: 18083707 [TBL] [Abstract][Full Text] [Related]
30. Backbone and side chain 1H, 13C, and 15N assignments of the ubiquitin-like domain of human HOIL-1L, an essential component of linear ubiquitin chain assembly complex. Uekusa Y; Mimura S; Sasakawa H; Kurimoto E; Sakata E; Olivier S; Yagi H; Tokunaga F; Iwai K; Kato K Biomol NMR Assign; 2012 Oct; 6(2):177-80. PubMed ID: 22127525 [TBL] [Abstract][Full Text] [Related]
31. Kinetic Constraints in the Specific Interaction between Phosphorylated Ubiquitin and Proteasomal Shuttle Factors. Qin LY; Gong Z; Liu K; Dong X; Tang C Biomolecules; 2021 Jul; 11(7):. PubMed ID: 34356632 [TBL] [Abstract][Full Text] [Related]
32. Interactions between the three CIN85 SH3 domains and ubiquitin: implications for CIN85 ubiquitination. Bezsonova I; Bruce MC; Wiesner S; Lin H; Rotin D; Forman-Kay JD Biochemistry; 2008 Aug; 47(34):8937-49. PubMed ID: 18680311 [TBL] [Abstract][Full Text] [Related]
33. Novel insights into the mechanisms of CIN85 SH3 domains binding to Cbl proteins: solution-based investigations and in vivo implications. Ababou A; Pfuhl M; Ladbury JE J Mol Biol; 2009 Apr; 387(5):1120-36. PubMed ID: 19268472 [TBL] [Abstract][Full Text] [Related]
34. Diubiquitin-Based NMR Analysis: Interactions Between Lys6-Linked diUb and UBA Domain of UBXN1. Shahul Hameed D; van Tilburg GBA; Merkx R; Flierman D; Wienk H; El Oualid F; Hofmann K; Boelens R; Ovaa H Front Chem; 2019; 7():921. PubMed ID: 32039147 [TBL] [Abstract][Full Text] [Related]
35. TULA: an SH3- and UBA-containing protein that binds to c-Cbl and ubiquitin. Feshchenko EA; Smirnova EV; Swaminathan G; Teckchandani AM; Agrawal R; Band H; Zhang X; Annan RS; Carr SA; Tsygankov AY Oncogene; 2004 Jun; 23(27):4690-706. PubMed ID: 15107835 [TBL] [Abstract][Full Text] [Related]
36. E2-c-Cbl recognition is necessary but not sufficient for ubiquitination activity. Huang A; de Jong RN; Wienk H; Winkler GS; Timmers HT; Boelens R J Mol Biol; 2009 Jan; 385(2):507-19. PubMed ID: 18996392 [TBL] [Abstract][Full Text] [Related]
37. The HIP2~ubiquitin conjugate forms a non-compact monomeric thioester during di-ubiquitin synthesis. Cook BW; Barber KR; Shilton BH; Shaw GS PLoS One; 2015; 10(3):e0120318. PubMed ID: 25799589 [TBL] [Abstract][Full Text] [Related]
38. C-Terminal acidic domain of ubiquitin-conjugating enzymes: a multi-functional conserved intrinsically disordered domain in family 3 of E2 enzymes. Arrigoni A; Grillo B; Vitriolo A; De Gioia L; Papaleo E J Struct Biol; 2012 Jun; 178(3):245-59. PubMed ID: 22507829 [TBL] [Abstract][Full Text] [Related]
39. Structure of the catalytic and ubiquitin-associated domains of the protein kinase MARK/Par-1. Panneerselvam S; Marx A; Mandelkow EM; Mandelkow E Structure; 2006 Feb; 14(2):173-83. PubMed ID: 16472737 [TBL] [Abstract][Full Text] [Related]
40. Independent interactions of ubiquitin-binding domains in a ubiquitin-mediated ternary complex. Garner TP; Strachan J; Shedden EC; Long JE; Cavey JR; Shaw B; Layfield R; Searle MS Biochemistry; 2011 Oct; 50(42):9076-87. PubMed ID: 21923101 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]